The primary benefit of imetelstat lies in its targeted approach to cancer treatment. By directly inhibiting telomerase, it offers a novel treatment avenue that is distinct from traditional chemotherapy and radiation. This targeted therapy approach has the potential to minimize side effects while maximizing therapeutic efficacy. Additionally, imetelstat has shown the ability to overcome resistance to other treatments, making it a valuable option in refractory or relapsed cancers.
